TRVI — TREVI THERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 229 家机构在其最新 13F 申报中持有 TRVI(TREVI THERAPEUTICS INC),合计申报市值 $2.91B,对应 157.12M 股。按股数计算较上季度增持 5.4%(+7.41M 股),申报市值环比上升 63.6%。持仓集中度较高:前五大持有人占申报市值的 33.7%,前十大的集中度为 48.7%。
与上一季度相比,45 家新建仓位、89 家加仓、58 家减仓、22 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
TREVI THERAPEUTICS INC(TRVI)的主要机构持有人包括 NEA Management Company, LLC、Fidelity Management & Research (FMR)、Frazier Life Sciences Management, L.P.,按 13F 申报市值在本页 339 家持有人中排名居前。
TRVI 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
持有 TRVI 的传奇投资人
我们追踪的超级投资人在各自最新 13F 申报中持有 TRVI 的名单——每位投资人按其自身最近一个季度展示。
| 投资人 | 季度 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|---|
|
|
Q2 2026 | 1.54M | $28.81M | 0.08% | 减持 |
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 154 | 81.33M | $1.16B | +8.6% |
| Q2 2026 | 229 | 157.12M | $2.91B | +5.4% |
| Q1 2026 | 206 | 142.59M | $1.71B | +3.3% |
| Q4 2025 | 191 | 135.40M | $1.69B | -5.9% |
| Q3 2025 | 174 | 138.95M | $1.27B | +19.0% |
| Q2 2025 | 159 | 115.77M | $633.07M | +24.4% |
| Q1 2025 | 145 | 93.49M | $587.83M | -2.1% |
| Q4 2024 | 112 | 82.25M | $340.78M | +12.5% |
表内 8 个季度中,机构持股合计减少 1%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2025(+24.4%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 13.22M | $120.98M | 6.64% | 持有 | |
| 10.26M | $93.87M | 2.81% | 持有 | |
| 9.90M | $90.59M | 0.00% | 增持 | |
| 8.53M | $78.07M | 0.89% | 持有 | |
| 5.83M | $53.32M | 0.00% | 增持 | |
| 5.13M | $46.93M | 0.12% | 增持 | |
| 5.13M | $46.93M | 0.12% | 增持 | |
| 5.09M | $46.62M | 3.75% | 增持 | |
| 4.84M | $44.30M | 0.07% | 增持 | |
| 4.30M | $39.36M | 0.00% | 增持 | |
| 4.29M | $39.28M | 0.01% | 持有 | |
| 3.41M | $31.17M | 5.10% | 持有 | |
| 3.31M | $30.27M | 0.78% | 持有 | |
| 3.30M | $30.19M | 0.00% | 增持 | |
| 3.25M | $29.77M | 0.01% | 增持 | |
| 3.25M | $29.77M | 0.01% | 增持 | |
| 2.81M | $25.76M | 4.02% | 减持 | |
| 2.80M | $25.62M | 2.47% | 增持 | |
| 2.54M | $23.21M | 0.91% | 减持 | |
| 2.22M | $20.33M | 0.00% | 增持 | |
| 2.22M | $20.31M | 0.00% | 增持 | |
| 2.20M | $20.13M | 2.12% | 增持 | |
| 2.14M | $19.63M | 9.96% | 持有 | |
| 2.00M | $18.30M | 3.52% | 增持 | |
| 1.84M | $16.81M | 0.00% | 增持 |
Q2 2025 — 25 家基金
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 2.93M 股 · $54.62M
- First Light Asset Management, LLC 2.10M 股 · $39.11M
- Assenagon Asset Management S.A. 1.53M 股 · $28.45M
- Jupiter Topco LLC 1.19M 股 · $22.19M
- Saturn V Capital Management LP 1.05M 股 · $19.62M
- Sixth Street Partners Management Company, L.P. 965.40K 股 · $18.00M
- Informed Momentum Co LLC 264.63K 股 · $4.94M
- Rock Springs Capital Management LP 260.00K 股 · $4.85M
- Trexquant Investment LP 242.54K 股 · $4.52M
- Walleye Capital LLC 241.99K 股 · $4.51M
- Integral Health Asset Management, LLC 200.00K 股 · $3.73M
- SEVEN GRAND MANAGERS, LLC 150.00K 股 · $2.80M
完全清仓(较上季)
- STATE STREET CORP 卖出 2.67M 股 · $31.80M
- Millennium Management 卖出 570.97K 股 · $6.81M
- MILLENNIUM MANAGEMENT LLC 卖出 570.97K 股 · $6.81M
- GMT CAPITAL CORP 卖出 317.70K 股 · $3.79M
- Swiss Life Asset Management Ltd 卖出 21.43K 股 · $3.66M
- Propel Bio Management, LLC 卖出 223.80K 股 · $2.65M
- Squarepoint Ops LLC 卖出 103.97K 股 · $1.24M
- ExodusPoint Capital Management, LP 卖出 79.86K 股 · $952.72K
- Simplify Asset Management Inc. 卖出 65.41K 股 · $780.37K
- Two Sigma Investments 卖出 38.41K 股 · $458.29K
- Janus Henderson Group 卖出 37.13K 股 · $442.55K
- AQR Capital Management 卖出 28.15K 股 · $335.82K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 13.63M | 12.56M | 8.04M | 6.50M | 3.30M | 368.53K | 6.00K | 4.36K | 3.69K | 3.60K | 3.54K | 3.51K | 1.58K | 886 | — | — | 1.56M | 83.22K | — | — |
| BlackRock Inc | 12.29M | 11.16M | 10.24M | 10.13M | 9.90M | 8.21M | 5.31M | 3.93M | 3.22M | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.11M | 5.53M | 4.98M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Vivo Capital, LLC | 4.23M | 5.09M | 5.09M | 5.09M | 5.09M | 4.49M | 3.49M | 3.49M | 1.61M | — | — | — | — | — | — | — | — | — | — | — |
| Assenagon Asset Management S.A. | 3.53M | 1.53M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 3.27M | — | 2.67M | 2.44M | 2.22M | 1.83M | 1.42M | 1.17M | 952.91K | 899.86K | 798.25K | 741.19K | 708.59K | — | — | — | — | — | — | — |
| Marshall Wace | 3.15M | 2.67M | 3.97M | 4.58M | 4.84M | 2.48M | 2.55M | 42.92K | 81.12K | — | — | — | — | — | — | — | 128.32K | — | 23.40K | — |
| Geode Capital Management | 2.96M | 2.93M | 2.78M | 2.41M | 2.22M | 1.79M | 1.61M | 1.30M | 1.26M | 1.15M | 897.97K | 849.88K | 787.64K | 778.82K | 248.29K | 211.55K | 200.22K | 195.15K | 72.74K | 49.08K |
| EVENTIDE ASSET MANAGEMENT, LLC | 2.55M | 2.66M | 2.62M | 2.62M | 1.38M | 1.38M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Pictet Asset Management Holding SA | 1.95M | 2.01M | 1.71M | 1.53M | 11.26K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 1.80M | 1.80M | 2.00M | 2.15M | 2.80M | 2.53M | 1.25M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EMERALD ADVISERS, LLC | 1.80M | 1.80M | 1.84M | 1.89M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.74M | 1.74M | 1.55M | 1.26M | 1.26M | 1.15M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Siren, L.L.C. | 1.52M | 1.79M | 1.79M | 2.29M | 2.54M | 3.94M | 2.86M | 2.91M | — | — | — | — | — | — | — | — | — | — | — | — |
| Jones Hill Capital LP | 1.45M | 1.34M | 370.18K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Candriam S.C.A. | 1.31M | 966.22K | 773.62K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.19M | 1.18M | 968.59K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1.18M | 1.21M | 1.26M | 1.27M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NAN FUNG TRINITY (HK) Ltd | 1.08M | 1.21M | 1.14M | 917.45K | 89.58K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 1.05M | 1.04M | 1.06M | 1.05M | 1.05M | 86.95K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold TRVI?
As of 2026-Q2, 229 institutional funds reported holding TRVI (TREVI THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $2.91B.
How many shares of TRVI do institutions own?
13F filers reported 157.12M shares of TRVI, worth $2.91B in aggregate at the end of 2026-Q2.
Is institutional ownership of TRVI rising or falling?
Share counts moved +5.4% versus the prior quarter — accumulation.
Who are the top institutional holders of TRVI?
The largest 13F holders are NEA Management Company, LLC, Fidelity Management & Research (FMR), Frazier Life Sciences Management, L.P., BlackRock Inc, Wellington Management Group; the top 25 are ranked at the top of this page.
Who are the major shareholders of TREVI THERAPEUTICS INC?
The major shareholders of TREVI THERAPEUTICS INC (TRVI) by reported 13F value are NEA Management Company, LLC, Fidelity Management & Research (FMR), Frazier Life Sciences Management, L.P., BlackRock Inc, Wellington Management Group, among 339 institutional holders.
Which legendary investors own TRVI?
1 of the legendary investors tracked on HoldingsHub report TRVI (TREVI THERAPEUTICS INC) in their latest 13F filings, led by Viking Global Investors. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on TRVI?
1 tracked superinvestors hold TRVI simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.